258 related articles for article (PubMed ID: 29023988)
1. Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity.
Shi D; Bai Q; Zhou S; Liu X; Liu H; Yao X
Proteins; 2018 Jan; 86(1):43-56. PubMed ID: 29023988
[TBL] [Abstract][Full Text] [Related]
2. Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.
Mustafi SM; LeMaster DM; Hernández G
Biochem J; 2014 Jul; 461(1):115-23. PubMed ID: 24749623
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
4. Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.
LeMaster DM; Mustafi SM; Brecher M; Zhang J; Héroux A; Li H; Hernández G
J Biol Chem; 2015 Jun; 290(25):15746-15757. PubMed ID: 25953903
[TBL] [Abstract][Full Text] [Related]
5. FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity.
Cox MB; Riggs DL; Hessling M; Schumacher F; Buchner J; Smith DF
Mol Endocrinol; 2007 Dec; 21(12):2956-67. PubMed ID: 17717070
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.
Bauder M; Meyners C; Purder PL; Merz S; Sugiarto WO; Voll AM; Heymann T; Hausch F
J Med Chem; 2021 Mar; 64(6):3320-3349. PubMed ID: 33666419
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
Voll AM; Meyners C; Taubert MC; Bajaj T; Heymann T; Merz S; Charalampidou A; Kolos J; Purder PL; Geiger TM; Wessig P; Gassen NC; Bracher A; Hausch F
Angew Chem Int Ed Engl; 2021 Jun; 60(24):13257-13263. PubMed ID: 33843131
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibitors of the FK506-binding protein 51 by induced fit.
Gaali S; Kirschner A; Cuboni S; Hartmann J; Kozany C; Balsevich G; Namendorf C; Fernandez-Vizarra P; Sippel C; Zannas AS; Draenert R; Binder EB; Almeida OF; Rühter G; Uhr M; Schmidt MV; Touma C; Bracher A; Hausch F
Nat Chem Biol; 2015 Jan; 11(1):33-7. PubMed ID: 25436518
[TBL] [Abstract][Full Text] [Related]
9. C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90.
Cheung-Flynn J; Roberts PJ; Riggs DL; Smith DF
J Biol Chem; 2003 May; 278(19):17388-94. PubMed ID: 12611898
[TBL] [Abstract][Full Text] [Related]
10. Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design.
LeMaster DM; Hernandez G
Curr Mol Pharmacol; 2015; 9(1):5-26. PubMed ID: 25986571
[TBL] [Abstract][Full Text] [Related]
11. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.
Wu B; Li P; Liu Y; Lou Z; Ding Y; Shu C; Ye S; Bartlam M; Shen B; Rao Z
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8348-53. PubMed ID: 15159550
[TBL] [Abstract][Full Text] [Related]
12. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
[TBL] [Abstract][Full Text] [Related]
13. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction.
Wang L; Kumar R; Winblad B; Pavlov PF
Eur J Med Chem; 2024 Apr; 270():116356. PubMed ID: 38579621
[TBL] [Abstract][Full Text] [Related]
15. Binding modes and conformational changes of FK506-binding protein 51 induced by inhibitor bindings: insight into molecular mechanisms based on multiple simulation technologies.
Chen J; Yin B; Pang L; Wang W; Zhang JZH; Zhu T
J Biomol Struct Dyn; 2020 Apr; 38(7):2141-2155. PubMed ID: 31198099
[TBL] [Abstract][Full Text] [Related]
16. Combined x-ray crystallography and computational modeling approach to investigate the Hsp90 C-terminal peptide binding to FKBP51.
Kumar R; Moche M; Winblad B; Pavlov PF
Sci Rep; 2017 Oct; 7(1):14288. PubMed ID: 29079741
[TBL] [Abstract][Full Text] [Related]
17. A Novel Decalin-Based Bicyclic Scaffold for FKBP51-Selective Ligands.
Feng X; Sippel C; Knaup FH; Bracher A; Staibano S; Romano MF; Hausch F
J Med Chem; 2020 Jan; 63(1):231-240. PubMed ID: 31800244
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity.
Denny WB; Prapapanich V; Smith DF; Scammell JG
Endocrinology; 2005 Jul; 146(7):3194-201. PubMed ID: 15802496
[TBL] [Abstract][Full Text] [Related]
19. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
[TBL] [Abstract][Full Text] [Related]
20. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes.
Barent RL; Nair SC; Carr DC; Ruan Y; Rimerman RA; Fulton J; Zhang Y; Smith DF
Mol Endocrinol; 1998 Mar; 12(3):342-54. PubMed ID: 9514152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
